Towards personalized treatment of smoking-related lung cancers

Nature

  • RESEARCH SUMMARY

Towards personalized treatment of smoking-related lung cancers

Access options

doi: https://doi.org/10.1038/d41586-021-01113-9

References

  1. 1.

    Jamal-Hanjani, M. et al. N. Engl. J. Med. 376, 2109–2121 (2017).

    PubMed 
    Article 

    Google Scholar
     

  2. 2.

    Blakely, C. M. et al. Nature Genet. 49, 1693–1704 (2017).

    PubMed 
    Article 

    Google Scholar
     

  3. 3.

    Castiglione, R. et al. Mod. Pathol. 32, 627–638 (2019).

    PubMed 
    Article 

    Google Scholar
     

  4. 4.

    McFadden, D. G. et al. Proc. Natl Acad. Sci. USA 113, E6409–E6417 (2016).

    PubMed 
    Article 

    Google Scholar
     

  5. 5.

    Yuan, G. et al. Nature 590, 504–508 (2021).

    PubMed 
    Article 

    Google Scholar
     

Download references

Competing Interests

G.M. reported receiving research funding from Bristol-Myers Squibb, Kael-Gemvax, Merck Sharp & Dome and Plexxikon, and personal fees from BioLineRx, Boehringer Ingelheim, Bristol-Myers Squibb, Merck Sharp & Dome and Roche.

Subjects

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.





Products You May Like

Articles You May Like

‘Summer of indigestion’ will produce big buying opportunities, long-term market bull Tony Dwyer predicts
First Case of Rare Monkeypox Detected in Texas Resident Who Traveled to Nigeria
Ancient star likely created from a colossal hypernova explosion
China launches secretive suborbital vehicle for reusable space transportation system
Influential US climate report moves ahead — under new leadership

Leave a Reply

Your email address will not be published. Required fields are marked *